Back to search

Article

Multi-Timepoint Risk Stratification in Rare Cancers: A Computational Framework Validated against Published Ewing Sarcoma Trial Data

2026-07-07

Abstract excerpt

Three audiences — the family of a newly diagnosed Ewing sarcoma patient, the long-term survivor, and the cooperative-group trial statistician — receive cohort-mean answers to patient-level questions because the patient-level data machine learning requires do not exist for rare cancers. We present a framework producing patient-level predictions from published aggregate trial data. A six-stage discrete-event Monte C...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
887b5abf-59f8-5304-8d73-4cc536b78f29
DOI
10.64898/2026.07.03.26357236
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multi-Timepoint Risk Stratification in Rare Cancers: A Computational Framework Validated against Published Ewing Sarcoma Trial DataDOI 10.64898/2026.07.03.26357236
Select a neighboring publication to make it the new centre.